78 related articles for article (PubMed ID: 8535316)
21. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
22. Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4+ T cells in allogeneic bone marrow transplantation recipients.
Vavassori M; Maccario R; Moretta A; Comoli P; Wack A; Locatelli F; Lanzavecchia A; Maserati E; Dellabona P; Casorati G; Montagna D
J Immunol; 1996 Dec; 157(12):5739-47. PubMed ID: 8955228
[TBL] [Abstract][Full Text] [Related]
23. Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients.
Hingorani R; Monteiro J; Furie R; Chartash E; Navarrete C; Pergolizzi R; Gregersen PK
J Immunol; 1996 Jan; 156(2):852-8. PubMed ID: 8543842
[TBL] [Abstract][Full Text] [Related]
24. T-cell receptor repertoire in neuroblastoma patients.
Valteau D; Scott V; Carcelain G; Hartmann O; Escudier B; Hercend T; Triebel F
Cancer Res; 1996 Jan; 56(2):362-9. PubMed ID: 8542593
[TBL] [Abstract][Full Text] [Related]
25. Reconstitution of the T cell receptor alpha beta repertoire in recipients of allogeneic BMT.
Rencher SD; Hanif I; Heslop HE; Turner VE; Brenner MK; Hurwitz JL
Bone Marrow Transplant; 1992 Dec; 10(6):521-7. PubMed ID: 1490202
[TBL] [Abstract][Full Text] [Related]
26. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P
Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation.
Liu C; He M; Rooney B; Kepler TB; Chao NJ
Biol Blood Marrow Transplant; 2006 Mar; 12(3):335-45. PubMed ID: 16503503
[TBL] [Abstract][Full Text] [Related]
28. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
29. Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults.
Jiménez M; Martínez C; Ercilla G; Carreras E; Urbano-Ispízua A; Aymerich M; Villamor N; Amézaga N; Rovira M; Fernández-Avilés F; Montserrat E
Transpl Immunol; 2006 Jun; 16(1):52-9. PubMed ID: 16701177
[TBL] [Abstract][Full Text] [Related]
30. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
[TBL] [Abstract][Full Text] [Related]
31. Expansions of clonal and oligoclonal T cells in B-cell chronic lymphocytic leukemia are primarily restricted to the CD3(+)CD8(+) T-cell population.
Goolsby CL; Kuchnio M; Finn WG; Peterson L
Cytometry; 2000 Jun; 42(3):188-95. PubMed ID: 10861692
[TBL] [Abstract][Full Text] [Related]
32. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
33. [T cell repertoires correlate with pathogenesis of chronic idiopathic thrombocytopenic purpura].
Zhu X; Zhu P; Guo XL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3316-22. PubMed ID: 16409835
[TBL] [Abstract][Full Text] [Related]
34. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
35. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
[TBL] [Abstract][Full Text] [Related]
36. Prethymic expression of a transgenic TCR beta chain on a precursor of T-cells.
Lincoln GC; Sheng B; Odebralski J; Lucchetta R; Smith RT
Cell Immunol; 1997 Oct; 181(1):1-12. PubMed ID: 9344490
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
38. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
[TBL] [Abstract][Full Text] [Related]
39. Signal transduction by B and T cells early after bone marrow transplantation: B cell calcium flux responses are intact whereas lack of CD4 cells accounts for impaired T cell responses.
Jin NR; Lum LG; Buren EV; Lerman SP; Walker AL; June CH
Bone Marrow Transplant; 1995 Jul; 16(1):103-9. PubMed ID: 7581108
[TBL] [Abstract][Full Text] [Related]
40. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
Pabst C; Schirutschke H; Ehninger G; Bornhäuser M; Platzbecker U
Clin Cancer Res; 2007 May; 13(10):2916-22. PubMed ID: 17504991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
